Tentative Scientific Program (subject to change):

Friday, 16 March 2012

08.50 – 08.55 Welcome , Eurolam Retina Presentation

                     (Borja Corcóstegui, Spain; David Pelayes, Argentina)
08.55 – 09.00 ESASO Presentation

                     (Borja Corcóstegui, Spain; Giuseppe Guarnaccia, Italy; David Pelayes, Argentina)

Section I: Perspectives on the diagnosis and treatment of diabetic masular edema

Coordinators: Neil Bressler, USA; Paul Mitchell, Australia; Francesco Bandello, Italy
09.00 – 09.10 DME Pathophysiology in relation to current therapeutic (René Cano, Mexico)
09.10 – 09.20 DME Risk Factors Magno (Ferreira, Brazil)
09.20 – 09.35 Anti VEGF Era in DME (Francesco Bandello, Italy)
09.35 – 09.45 The combined treatment of diabetic macular edema (Edoardo Midena, Italy)
09.45 – 10.00 Clinical Implications of the Diabetic Retinopathy Clinical Research Network

                     Treatment Approach to Diabetic Macular Edema (Neil Bressler, USA)
10.00 – 10.10 Case presentation DME (Clara Varón, Colombia)
10.10 – 10.20 Case presentation DME (Gabriel Dib, Venezuela)
10.20 – 10.30 DME New laser technologies (David Pelayes, Argentina)
10.30 – 11.00 Questions/Discussion
11.00 – 11.30 Coffee Break Foyer

Section II: Surgical Management DME and DPR

Coordinators: Tarek Hassan, USA; Ferenc Kuhn, USA/Hungary; Marcio Nehemy, Brazil
11.30 – 11.45 Safety and Performance: The new reality on MIVS surgery (Marcio Nehemy, Brazil)
11.45 – 12.00 The Current State of Vitrectomy for Diabetic Macular Edema (Tarek Hassan, USA)
12.00 – 12.15 Proliferative Diabetic Retinopathy, Modern Surgical Strategies

                     (Borja Corcóstegui, Spain)
12.15 – 12.30 Late versus prophylactic chorioretinectomy for the prevention of trauma-related

                     proliferative vitreoretinopathy (Ferenc Kuhn, USA/Hungary)
12.45 – 12.55 Ideas to minimize retina traction on modern vitreoretinal surgery

                     (Danilo Soriano, Brazil)
12.55 – 13.02 Case Presentation (Carlos Abdala, Colombia)
13.02 – 13.09 Case Presentation Andrés Bastien, Argentina
13.09 – 13.16 Case Presentation Gisbert Richard, Germany
13.16 – 13.30 Questions / Discussion
13.30 – 14.30 Lunch

Section III: Recent developments in the management of RVO

Coordinators: Anat Lowenstein, Israel; Rafael Cortez, Venezuela; Federico Graue, Mexico
14.30 – 14.45 Treatment of Macular Edema Secondary Branch VO (Federico Graue, Mexico)
14.45 – 15.00 Duration of the macular edema and treatment outcome in Branch RVO

                     (Andre Vieira Gomes, Brazil)
15.00 – 15.15 Physiopathology and Risk Factors in CVO (Ivan Sepulveda, Chile)
15.15 – 15.30 Treatment of Macular Edema Secondary CVO (Francesco Bandello, Italy)
15.30 – 15.45 Treatment of CVO with Neovascularization (Rafael Cortez, Venezuela)
15.45 – 16.00 Steroid treatment in vein occlusion (Anat Lowenstein, Israel)
16.00 – 16.10 Case Presentation (Hugo Ocampo Dominguez,Colombia)
16.10 – 16.20 Case Presentation (Juan Manuel Jiménez, Mexico)
16.20 – 16.30 Questions / Discussion
16.30 – 17.00 Coffee Break

Section IV: DME, DPR , RVO, others ME Case Presentation

Coordinators: Carlos Abdala, Colombia; Virgilio Morales Canton, Mexico; Rene Cano, Mexico; Gregorio Gabela, Ecuador; Ivan Sepulveda, Chile; Raul NG Viana, Brazil
17.00 – 17.07 Case Presentation (Martin Folgar, Argentina)
17.07 – 17.15 Case Presentation (Ferenc Kuhn, USA/Hungary)
17.15 – 17.22 Case Presentation (Jose Luis Rodriquez, Mexico)
17.22 – 17.29 Case Presentation (Ernesto Ramírez, Venezuela)
17.29 – 17.36 Case Presentation (Laurentino Biccas Neto, Brazil)
17.36 – 17.43 Case Presentation (Arun D. Singh, USA)
17.43 – 17.50 Case Presentation (Luis Felipe Rivero, Venezuela)
17.50 – 18.30 Questions / Discussion

Saturday, 17 March 2012

Section V Effective Diagnosis and Treatment of AMD

Coordinators: Borja Corcostegui, Spain; Gisbert Richard, Germany; David Pelayes, Argentina
08.30 – 08.45 The value of patient registers (Paul Mitchell, Australia)
08.45 – 09.00 Genetics and Risk Factors AMD (David Lozano, Mexico)
09.00 – 09.15 Evidence for treatment AMD (Borja Corcóstegui, Spain)
09.15 – 09.30 Early detection of macular degeneration (Anat Lowenstein, Israel)
09.30 – 09.45 Three Common Questions When Treating Neovascular AMD: Do I Have to Treat

                     Monthly? Can I Substitute Bevacizumab for Ranibizumab?

                     Are There Systemic Safety Risks? (Neil Bressler, USA)
09.45 – 10.00 Combination Therapies in AMD (Francesco Bandello, Italy)
10.00 – 10.15 CATT Study (Paul Mitchell, Australia)
10.15 – 10.25 Stem Cell future alternative in Dry AMD (David Pelayes, Argentina)
10.25 – 10.35 Stem Cell therapies, animal model for AMD (Gisbert Richard, Germany)
10.35 – 11.00 Coffee Break Foyer

Section VI Digital Images & other etiologies of choroidal neovascularization

Coordinators: Philip Rosenfeld, USA; Arun D. Singh, USA; Edoardo Midena, Italy
11.00 – 11.10 SD OCT in choroidal NV (Miguel Brito, Venezuela)
11.10 – 11.25 Fundus Autofluorescence in the Management of AMD (Philip Rosenfeld, USA)
11.25 – 11.35 Management NVM secondary to myopia (Catalina Montoya, Colombia)
11.35 – 11.45 Management of NVM secondary to polypoidal choroidal vasculopathy

                     (Danilo Soriano, Brazil)
11.45 – 11.55 Management RPE detachment (Gregorio Gabela, Ecuador)
11.55 – 12.05 Management Maculophaty Post Radiation Arun D. Singh, USA
12.05 – 12.15 Management NVM secondary to angioid streaks (Daniel Colombero, Argentina)
12.15 – 13.02 Case Presentation (Juan G Sanchez, Venezuela)
13.02 – 13.09 Case Presentation (Antonio Lopez Bolanos, Mexico)
13.09 – 13.16 Case Presentation (Esteban Velasteguí, Ecuador)
13.16 – 13.23 Case Presentation (Juan Verdaguer, Chile)
13.23 – 13.30 Case Presentation (Philip Rosenfeld, USA)
13.30 – 14.00 Questions / Discussion
14.00 – 14.30 Close of Congress, Presentation III
                     Macula & Retina Congress Eurolam ESASO 2013

Tentatively confirmed Speakers will include:

Neil M Bressler: The Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD, USA
Francesco Bandello: Scientific Institute San Raffaele, Milan, Italy
Tarek S. Hassan: Clinical Assistant Professor of Biomedical Sciences at Oakland University in Rochester, Michigan, USA
Ferenc Kuhn: Associate Clinical Professor of Ophthalmology at the University of Alabama at Birmingham, USA
Anat Loewenstein: Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Edoardo Midena: Professor of Ophthalmology and visual Sciences at the University of Padova, School of Medicine, and Chairman of the Department of Ophthalmology, Padova, Italy
Paul Mitchell: Department of Ophthalmology, University of Sydney, Sydney, Australia
Gisbert Richard: Head of Ophthalmology Department, University Medical Center Hamburg-Eppendorf, Germany
Philip Rosenfeld: Professor of Ophthalmology at the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, Miami, Florida, USA
Arun D. Singh: Professor of Ophthalmology, Director, Department of Ophthalmic Oncology Cole Eye Institute, Cleveland Clinic Foundation Cleveland, Ohio USA